| pubmed-article:9506349 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9506349 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:9506349 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:9506349 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:9506349 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:9506349 | lifeskim:mentions | umls-concept:C0030956 | lld:lifeskim |
| pubmed-article:9506349 | lifeskim:mentions | umls-concept:C1521970 | lld:lifeskim |
| pubmed-article:9506349 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:9506349 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
| pubmed-article:9506349 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:9506349 | pubmed:dateCreated | 1998-3-25 | lld:pubmed |
| pubmed-article:9506349 | pubmed:abstractText | Progastrin-releasing peptide (proGRP) is a specific tumor marker in patients with small cell lung carcinoma (SCLC). It has been reported that serum proGRP levels rarely are elevated in patients with nonsmall cell lung carcinoma (NSCLC); the reported frequency is <3%. The purpose of this study was to examine the clinicopathologic features of NSCLC patients with high serum proGRP levels. | lld:pubmed |
| pubmed-article:9506349 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9506349 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9506349 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9506349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9506349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9506349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9506349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9506349 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9506349 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:9506349 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:9506349 | pubmed:author | pubmed-author:MatsumotoTT | lld:pubmed |
| pubmed-article:9506349 | pubmed:author | pubmed-author:KodamaTT | lld:pubmed |
| pubmed-article:9506349 | pubmed:author | pubmed-author:GotoKK | lld:pubmed |
| pubmed-article:9506349 | pubmed:author | pubmed-author:KubotaKK | lld:pubmed |
| pubmed-article:9506349 | pubmed:author | pubmed-author:NagaiKK | lld:pubmed |
| pubmed-article:9506349 | pubmed:author | pubmed-author:SekineII | lld:pubmed |
| pubmed-article:9506349 | pubmed:author | pubmed-author:NishiwakiYY | lld:pubmed |
| pubmed-article:9506349 | pubmed:author | pubmed-author:OhmatsuHH | lld:pubmed |
| pubmed-article:9506349 | pubmed:author | pubmed-author:HojoFF | lld:pubmed |
| pubmed-article:9506349 | pubmed:author | pubmed-author:KakinumaRR | lld:pubmed |
| pubmed-article:9506349 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9506349 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:9506349 | pubmed:volume | 82 | lld:pubmed |
| pubmed-article:9506349 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9506349 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9506349 | pubmed:pagination | 1056-61 | lld:pubmed |
| pubmed-article:9506349 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:9506349 | pubmed:meshHeading | pubmed-meshheading:9506349-... | lld:pubmed |
| pubmed-article:9506349 | pubmed:meshHeading | pubmed-meshheading:9506349-... | lld:pubmed |
| pubmed-article:9506349 | pubmed:meshHeading | pubmed-meshheading:9506349-... | lld:pubmed |
| pubmed-article:9506349 | pubmed:meshHeading | pubmed-meshheading:9506349-... | lld:pubmed |
| pubmed-article:9506349 | pubmed:meshHeading | pubmed-meshheading:9506349-... | lld:pubmed |
| pubmed-article:9506349 | pubmed:meshHeading | pubmed-meshheading:9506349-... | lld:pubmed |
| pubmed-article:9506349 | pubmed:meshHeading | pubmed-meshheading:9506349-... | lld:pubmed |
| pubmed-article:9506349 | pubmed:meshHeading | pubmed-meshheading:9506349-... | lld:pubmed |
| pubmed-article:9506349 | pubmed:meshHeading | pubmed-meshheading:9506349-... | lld:pubmed |
| pubmed-article:9506349 | pubmed:meshHeading | pubmed-meshheading:9506349-... | lld:pubmed |
| pubmed-article:9506349 | pubmed:meshHeading | pubmed-meshheading:9506349-... | lld:pubmed |
| pubmed-article:9506349 | pubmed:meshHeading | pubmed-meshheading:9506349-... | lld:pubmed |
| pubmed-article:9506349 | pubmed:meshHeading | pubmed-meshheading:9506349-... | lld:pubmed |
| pubmed-article:9506349 | pubmed:meshHeading | pubmed-meshheading:9506349-... | lld:pubmed |
| pubmed-article:9506349 | pubmed:meshHeading | pubmed-meshheading:9506349-... | lld:pubmed |
| pubmed-article:9506349 | pubmed:meshHeading | pubmed-meshheading:9506349-... | lld:pubmed |
| pubmed-article:9506349 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9506349 | pubmed:articleTitle | Clinicopathologic characteristics of patients with nonsmall cell lung carcinoma with elevated serum progastrin-releasing peptide levels. | lld:pubmed |
| pubmed-article:9506349 | pubmed:affiliation | Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. | lld:pubmed |
| pubmed-article:9506349 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9506349 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
